Literature DB >> 22596101

Partial p16 staining in oropharyngeal squamous cell carcinoma: extent and pattern correlate with human papillomavirus RNA status.

James S Lewis1, Rebecca D Chernock, Xiao-Jun Ma, John J Flanagan, Yuling Luo, Ge Gao, Xiaowei Wang, Samir K El-Mofty.   

Abstract

Human papillomavirus (HPV)-related oropharyngeal squamous cell carcinoma has unique biology and better outcomes. p16 immunostaining is used as a surrogate marker for transcriptionally active HPV. Although diffuse staining is generally accepted as positive, the significance of partial staining has not been established, nor has the cutoff for extent of p16 staining that should be used to identify a tumor as HPV-related. From three other large studies utilizing p16 immunohistochemistry, we identified all cases with partial positive staining. The p16-stained slides were reviewed by three study pathologists for staining (nuclear and cytoplasmic) extent (in quartiles), and also for percentage that was confluent (ie, back-to-back cell staining). Tumors were histologically typed (keratinizing, non-keratinizing, or non-keratinizing with maturation) and tested for high-risk HPV by RNA in-situ hybridization and reverse-transcriptase PCR. For the 16 cases, there were two 4+(13%), five 3+(31%), six 2+(38%), and three 1+(19%) p16 staining tumors. Extent of staining ranged from 5 to 90% of cells positive with 25% or more confluent staining in 4/16 (25%). Of the 16 (31%) cases, 5 were HPV-related on the basis of RNA in-situ hybridization and reverse-transcriptase PCR. All of these cases had >50% p16 staining, 4/5 (80%) had more than 25% confluent staining, and 4/7 (57%) had non-keratinizing histological features. Only one of the p16 1+/2+ tumors was HPV RNA-positive (by reverse-transcriptase PCR only and low level). All 1+/2+ cases were keratinizing type or undifferentiated. By sensitive detection methods, most partial p16-positive squamous cell carcinoma cases with >50% staining harbor transcriptionally active HPV, and most HPV+ tumors have significant amounts of confluent staining. Cases with <50% p16 staining and lacking significant confluent staining rarely harbor HPV. These results support that greater than 75% p16 staining or, alternatively, >50% staining combined with >25% confluent areas, are suitable cutoffs for defining positivity.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22596101     DOI: 10.1038/modpathol.2012.79

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  42 in total

1.  Comparison of high-dose Cisplatin-based chemoradiotherapy and Cetuximab-based bioradiotherapy for p16-positive oropharyngeal squamous cell carcinoma in the context of revised HPV-based staging.

Authors:  Bhattasali Onita; Thompson Lester D R; Abdalla Iman A; Chen Jergin; Iganej Shawn
Journal:  Rep Pract Oncol Radiother       Date:  2018-09-07

2.  Equivocal p16 immunostaining in squamous cell carcinoma of the head and neck: staining patterns are suggestive of HPV status.

Authors:  Zhongchuan Will Chen; Ilan Weinreb; Suzanne Kamel-Reid; Bayardo Perez-Ordoñez
Journal:  Head Neck Pathol       Date:  2012-07-17

3.  Tumor cell anaplasia and multinucleation are predictors of disease recurrence in oropharyngeal squamous cell carcinoma, including among just the human papillomavirus-related cancers.

Authors:  James S Lewis; Juliette B Scantlebury; Jingqin Luo; Wade L Thorstad
Journal:  Am J Surg Pathol       Date:  2012-07       Impact factor: 6.394

4.  A Retrospective 20-Year Analysis of Proliferative Verrucous Leukoplakia and Its Progression to Malignancy and Association with High-risk Human Papillomavirus.

Authors:  Jasbir D Upadhyaya; Sarah G Fitzpatrick; Mohammed N Islam; Indraneel Bhattacharyya; Donald M Cohen
Journal:  Head Neck Pathol       Date:  2018-02-09

5.  p16 immunohistochemistry in oropharyngeal squamous cell carcinoma: a comparison of antibody clones using patient outcomes and high-risk human papillomavirus RNA status.

Authors:  Jeremy Shelton; Bibianna M Purgina; Nicole A Cipriani; William D Dupont; Dale Plummer; James S Lewis
Journal:  Mod Pathol       Date:  2017-06-16       Impact factor: 7.842

Review 6.  Emerging biomarkers in head and neck cancer in the era of genomics.

Authors:  Hyunseok Kang; Ana Kiess; Christine H Chung
Journal:  Nat Rev Clin Oncol       Date:  2014-11-18       Impact factor: 66.675

7.  Distant metastasis in p16-positive oropharyngeal squamous cell carcinoma: a critical analysis of patterns and outcomes.

Authors:  P Sinha; W T Thorstad; B Nussenbaum; B H Haughey; D R Adkins; D Kallogjeri; J S Lewis
Journal:  Oral Oncol       Date:  2013-11-06       Impact factor: 5.337

8.  A novel prediction model for human papillomavirus-associated oropharyngeal squamous cell carcinoma using p16 and subcellular β-catenin expression.

Authors:  Guoqing Qian; Zhongliang Hu; Hong Xu; Susan Müller; Dongsheng Wang; Hongzheng Zhang; Sungjin Kim; Zhengjia Chen; Nabil F Saba; Dong M Shin; Andrew Y Wang; Zhuo Georgia Chen
Journal:  J Oral Pathol Med       Date:  2015-10-22       Impact factor: 4.253

9.  Human papillomavirus-related oropharyngeal cancer: HPV and p16 status in the recurrent versus parent tumor.

Authors:  Jeffrey Vainshtein; Jonathan B McHugh; Matthew E Spector; Heather M Walline; Christine M Komarck; Matthew H Stenmark; Mark E Prince; Francis P Worden; Gregory T Wolf; Carol R Bradford; Douglas B Chepeha; Thomas Carey; Avraham Eisbruch
Journal:  Head Neck       Date:  2014-04-15       Impact factor: 3.147

10.  The presence of high-risk human papillomavirus (HPV) E6/E7 mRNA transcripts in a subset of sinonasal carcinomas is evidence of involvement of HPV in its etiopathogenesis.

Authors:  Jan Laco; Kateřina Sieglová; Hana Vošmiková; Pavel Dundr; Kristýna Němejcová; Jaroslav Michálek; Petr Čelakovský; Viktor Chrobok; Radovan Mottl; Alena Mottlová; Luboš Tuček; Radovan Slezák; Marcela Chmelařová; Igor Sirák; Milan Vošmik; Aleš Ryška
Journal:  Virchows Arch       Date:  2015-07-31       Impact factor: 4.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.